Skip to content

Evaluation of Preventive Protocol for Central Venous Catheter-Related Infection (Antibiotic Lock Therapy and TauroLock) in Hemodialysis Patients.

Efficacy of Preventive Protocol for Central Venous Catheter-Related Infection (Antibiotic Lock Therapy and TauroLock) in Hemodialysis Patients.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210921052544N1
Enrollment
60
Registered
2022-05-01
Start date
2022-04-20
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Catheter infection. Condition 2: Hemodyalisis. Bloodstream infection due to central venous catheter, initial encounter Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group one( Taurolock manufactured by TauroPharm GmbH Company): At the end of each dialysis, the patient's premcath lines are filled with taurolock and each month blood cul

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All End Stage Renal Disease patients dialysis through permacath Presenting informed consent for attending in study

Exclusion criteria

Exclusion criteria: Poor blood flow during dialysis Past history of IV drug abusing Past history of active systemic infections before permacath insertion Change the catheter to AV fistula Past surgical history whitin the last year Past history of allergies to antibiotics

Design outcomes

Primary

MeasureTime frame
The rate of catheter infection in hemodialysis patients. Timepoint: Checking blood culture from catheter lines and peripheral blood at the end of each month. Method of measurement: Culture of catheter lines and peripheral blood.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Delgosha

Shahid Beheshti University of Medical Sciences

mary.delgosha@gmail.com+98 21 7343 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026